Loading...
menu
Search
Features
Markets
News
Resources
Pricing
Home
ETF
ACHV
ACHV
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
Latest ACHV ETF News Today | Earnings, Events & Price Alerts
ACHV News
Achieve Life Sciences Appoints Mark Rubinstein as Chief Medical Officer
Jan 12 2026
NASDAQ.COM
Achieve Life Sciences Submits NDA for Cytisinicline, Expected U.S. Launch in 2026
Dec 30 2025
Benzinga
Achieve Life Sciences to Host Investor Meetings at 2026 J.P. Morgan Healthcare Conference
Dec 17 2025
PRnewswire
Achieve Life Sciences Grants 250,000 Stock Options to New Chief Legal Officer
Dec 08 2025
Globenewswire
Citizens Begins Coverage of Achieve Life Sciences (ACHV) with a Positive Market Outlook
Nov 26 2025
NASDAQ.COM
Citizens Begins Coverage of Achieve Life Sciences with Market Outperform Rating and Sets Price Target at $19
Nov 25 2025
Benzinga
Achieve Life Sciences Awarded FDA Commissioner’s National Priority Voucher for Cytisinicline to Aid in E-cigarette and Vaping Addiction Treatment
Oct 17 2025
Newsfilter
Achieve, Disc, and Revolution Among Recipients of First FDA National Priority Vouchers
Oct 17 2025
SeekingAlpha
Achieve Life Sciences Publishes Data in Thorax Highlighting Cytisinicline's Potential Effectiveness and Tolerability for Smoking Cessation in COPD Patients
Sep 22 2025
Newsfilter
Achieve Life Sciences Elevates Craig Donnelly to Chief Operations Officer
Sep 18 2025
Newsfilter
Achieve Life Sciences Appoints New Interim Chief Medical Officer
Sep 12 2025
SeekingAlpha
Achieve Life Sciences Appoints Interim Chief Medical Officer
Sep 11 2025
Yahoo Finance
FDA Evaluating Achieve Life Sciences' Treatment for Nicotine Dependence
Sep 03 2025
SeekingAlpha
Achieve Life Sciences Moves Closer to FDA Approval for First New Smoking Cessation Drug in Two Decades
Aug 21 2025
Benzinga
Achieve (ACHV) Q2 Net Loss Hits $12.7M
Aug 07 2025
NASDAQ.COM
Achieve Life Sciences Reports Second Quarter 2025 Financial Results; Provides Updates on Cytisinicline Program
Aug 07 2025
Newsfilter
Show More News
